Biodelivery Sciences International reported $25.78M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 10.46M 805K
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Agile Therapeutics AGRX:US 17.84M 1.5M
Antares Pharma ATRS:US $ 38.19M 1.5M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Biodelivery Sciences International BDSI:US $ 25.78M 7.8M
Cara Therapeutics CARA:US $ 30.88M 5.38M
Cti Biopharma CTIC:US $ 19.51M 2.44M
Daiichi Sankyo 4568:JP 218.3B 31.09B
Depomed DEPO:US $ 37.37M 18.04M
Endo International Ordinary Shares ENDP:US $ 570.72M 35.49M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Knight Therapeutics Inc GUD:CN C$ 65.6M 17.23M
Lannett LCI:US $ 139.83M 30.31M
Mannkind MNKD:US $ 55.68M 32.06M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Pfizer PFE:US $ 13063M 3998M
Redhill Biopharma RDHL:US 46.39M 7.66M
Revance Therapeutics RVNC:US $ 89.14M 5.83M
Teva Pharmaceutical TEVA:IT 3.33B 220M